Stay updated on Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page.

Latest updates to the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page
- Check4 days agoChange DetectedThe page history now shows a new revision label 'Revision: v3.3.3'. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe Record History now includes a new revision tag 'Revision: v3.3.2' replacing the previous 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site-wide government funding/operating status notice was removed.SummaryDifference0.7%

- Check54 days agoChange DetectedNew history entries with status updates were added to the study record, including recruitment and study status changes.SummaryDifference0.2%

- Check83 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Activity of SBT6050 with HER2 Therapies Clinical Trial page.